Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms

被引:50
作者
Bhateja, Deepak Kumar [1 ]
Dhull, Dinesh K. [1 ]
Gill, Aneet [1 ]
Sidhu, Akramdeep [1 ]
Sharma, Saurabh [1 ]
Reddy, B. V. Krishna [1 ]
Padi, Satyanarayana S. V. [1 ]
机构
[1] ISF Coll Pharm, Dept Pharmacol, Neuropharmacol Div, Moga 142001, Punjab, India
关键词
Fenofibrate; Huntington's disease; MK886; 3-nitropropionic acid; Oxidative stress; NF-KAPPA-B; PPAR-ALPHA; OXIDATIVE STRESS; MICROGLIAL ACTIVATION; MITOCHONDRIAL TOXIN; HUNTINGTONS-DISEASE; STRIATAL DEGENERATION; EXPERIMENTAL-MODEL; SPINAL-CORD; CELL-DEATH;
D O I
10.1016/j.ejphar.2011.10.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peroxisome proliferators activated receptor is regarded as potential therapeutic targets to control various neurodegenerative disorders. However, none of the study has elucidated its effect in the treatment of Huntington's disease. We explored whether peroxisome proliferators activated receptor-a agonist may attenuate various behavioral and biochemical alterations induced by systemic administration of 3-nitropropionic acid (3-NP), an accepted experimental animal model of Huntington's disease phenotype. Intraperitoneal administration of 3-NP (20 mg/kg., i.p.) for 4 days in rats produced hypolocomotion, muscle incoordination, and cognitive dysfunction. Daily treatment with fenofibrate (100 or 200 mg/kg., p.o.), 30 min prior to 3-NP administration for a total of 4 days, significantly improved the 3-NP induced motor and cognitive impairment. Biochemical analysis revealed that systemic 3-NP administration significantly increased oxidative and nitrosative stress (increase lipid peroxidation, protein carbonyls and nitrite level), lactate dehydrogenase activity whereas, decreased the activities of catalase, superoxide dismutase, reduced glutathione, and succinate dehydrogenase. Fenofibrate treatment significantly attenuated oxidative damage, cytokines and improved mitochondrial complexes enzyme activity in brain. In the present study, MK886, a selective inhibitor of peroxisome proliferators activated receptor-a was employed to elucidate the beneficial effect through either receptor dependent or receptor independent neuroprotective mechanisms. Administration of MK886 (1 mg/kg, i.p.) prior to fenofibrate (200 mg/kg, p.o.) abolished the effect of fenofibrate. The results showed that receptor dependent neuroprotective effects of fenofibrate in 3-NP administered rats provide a new evidence for a role of PPAR-a activation in neuroprotection that is attributed by modulating oxidative stress and inflammation. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 50 条
  • [1] Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity
    Ahuja, Manuj
    Bishnoi, Mahendra
    Chopra, Kanwaljit
    [J]. TOXICOLOGY, 2008, 244 (2-3) : 111 - 122
  • [2] BEAL MF, 1995, J NEUROCHEM, V65, P919
  • [3] BEAL MF, 1993, J NEUROSCI, V13, P4181
  • [4] Beltowski J, 2002, J PHYSIOL PHARMACOL, V53, P463
  • [5] Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation
    Benani, A
    Heurtaux, T
    Netter, P
    Minn, A
    [J]. NEUROSCIENCE LETTERS, 2004, 369 (01) : 59 - 63
  • [6] Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord
    Benani, A
    Krémarik-Bouillaud, P
    Bianchi, A
    Netter, P
    Minn, A
    Dauça, M
    [J]. JOURNAL OF CHEMICAL NEUROANATOMY, 2003, 25 (01) : 29 - 38
  • [7] Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury
    Besson, VC
    Chen, XR
    Plotkine, M
    Marchand-Verrecchia, C
    [J]. NEUROSCIENCE LETTERS, 2005, 388 (01) : 7 - 12
  • [8] PPARα blocks glucocorticoid receptor α-mediated transactivation but cooperates with the activated glucocorticoid receptor α for transrepression on NF-κB
    Bougarne, Nadia
    Paumelle, Rejane
    Caron, Sandrine
    Hennuyer, Nathalie
    Mansouri, Roxane
    Gervois, Philippe
    Staels, Bart
    Haegeman, Guy
    De Bosscher, Karolien
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (18) : 7397 - 7402
  • [9] 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
    Brouillet, E
    Jacquard, C
    Bizat, N
    Blum, D
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 95 (06) : 1521 - 1540
  • [10] Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury
    Chen, Xiao Ru
    Besson, Valerie C.
    Palmier, Bruno
    Garcia, Yannick
    Plotkine, Michel
    Marchand-Leroux, Catherine
    [J]. JOURNAL OF NEUROTRAUMA, 2007, 24 (07) : 1119 - 1131